Sunshine Biopharma (SBFM) Inventory (2019 - 2026)
Sunshine Biopharma's (SBFM) quarterly Inventory came in at $13.2 million in Q1 2026, up 11.06% YoY from $11.9 million in Q1 2025, and down 2.25% on a QoQ basis from $13.5 million in Q4 2025.
Sunshine Biopharma (SBFM) Inventory (2019 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 8 years of Inventory data on file, last reported at $13.2 million in Q1 2026.
- Quarterly Inventory rose 11.06% year-over-year to $13.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.2 million (up 11.06% YoY) and the FY2025 annual result came in at $13.5 million, up 19.45% from the prior year.
- Inventory retreated to $13.2 million in Q1 2026, from $13.5 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $14.1 million in Q3 2025 to a low of $181496.0 in Q1 2022.
- A 5-year average of $7.4 million and a median of $7.7 million in 2024 frame the typical range for Inventory.
- Annual changes were most pronounced in 2022 — Inventory soared 3014.0% — and 2026, when it grew 11.06%.
- Tracing SBFM's Inventory over 5 years: stood at $3.3 million in 2022, then jumped by 74.31% to $5.7 million in 2023, then soared by 96.66% to $11.3 million in 2024, then grew by 19.45% to $13.5 million in 2025, then slipped by 2.25% to $13.2 million in 2026.
- The last three Inventory figures came in at $13.2 million (Q1 2026), $13.5 million (Q4 2025), and $14.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.22 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 9.08 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 193.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.77 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 816.00 Mn |
| 10 | Sunshine Biopharma | 1.58 Mn | -12.17 Mn | 2.43 Mn | 12.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.12 Mn |
| Mar 31, 2026 | 13.17 Mn |
| Dec 31, 2025 | 13.47 Mn |
| Sep 30, 2025 | 14.06 Mn |
| Jun 30, 2025 | 13.02 Mn |
| Mar 31, 2025 | 11.86 Mn |
| Dec 31, 2024 | 11.28 Mn |
| Sep 30, 2024 | 9.82 Mn |
| Jun 30, 2024 | 8.49 Mn |
| Mar 31, 2024 | 7.70 Mn |
| Dec 31, 2023 | 5.73 Mn |
| Sep 30, 2023 | 4.52 Mn |
| Jun 30, 2023 | 4.25 Mn |
| Mar 31, 2023 | 3.71 Mn |
| Dec 31, 2022 | 3.29 Mn |
| Sep 30, 2022 | 269,641.00 |
| Jun 30, 2022 | 205,371.00 |
| Mar 31, 2022 | 181,496.00 |
| Dec 31, 2021 | 105,650.00 |
| Sep 30, 2021 | 71,310.00 |